Game-changing treatment for intervertebral disc (IVD) degeneration
NC Biomatrix has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in December 2022.
NC Biomatrix's investors include European Innovation Council, NLC.
NC Biomatrix is headquartered in Amsterdam, The Netherlands.
Game-changing treatment for intervertebral disc (IVD) degeneration
NC Biomatrix is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NC Biomatrix — Funding & Investors." VCBacked, December 19, 2022, https://www.vcbacked.co/company/nc-biomatrix. Accessed November 1, 2026.
VCBacked. (2022). NC Biomatrix — Funding & Investors. Retrieved November 1, 2026, from https://www.vcbacked.co/company/nc-biomatrix
{{cite web |title=NC Biomatrix — Funding & Investors |url=https://www.vcbacked.co/company/nc-biomatrix |website=VCBacked |access-date=November 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated